Introduction: Core products Quanming Ucheck (Urinary Monohydroxyphenol Derivative Determination Reagent) Taking biotechnology and life sciences as the forerunner, it covers the medical fields of healthcare, nutritional healthcare, checking, preventing, and partially treating cancers, etc., and is committed to improving the quality of life, enhancing the health of residents, and caring for life. The company is committed to improving the quality of life, enhancing the health of the population and caring for life. The company has a highly qualified R & D team and sophisticated marketing management team, with biochemistry core technology, and won the national patent, leading the world 5-10 years level, to fill the international cancer prevention testing technology project standardization and standardization of the blank. 2016 Zhejiang Kanglong Biotechnology Co., Ltd. is a high-tech biotechnology enterprise specializing in biological in vitro diagnostic reagents research and development, production, sales and service as a whole. Located in Ningbo, the fourth largest port city in the world, one of the five regional centers of Yangtze River Delta and the economic center of Zhejiang Province. At present, the company has developed and put into production the patented product "Urinary Monohydroxyphenol Derivative Determination Reagent" - an early cancer screening reagent, which has made great contributions to the cause of cancer prevention and fight against cancer for the whole mankind. A cancer ultra-early detection and screening reagent, through the detection of monohydroxyphenols in urine, can easily know the active degree of cancer cells in the human body, before the existing medical equipment can check the tumor, timely know their own physical condition, timely adjustments, to avoid the proliferation of cancer cells, so as to achieve early detection, early discovery and early prevention. It is applicable to a wide range of people, has a high recovery rate and is affordable. In July, Quanming U-Test - urine monohydroxyphenol derivatives determination reagent was born. In November, Quanming U-Test became the only large-scale health sponsor of "2016 Global Small and Medium-sized Enterprises Summit - Presidential Forum". In November, Quanming U-Test became the only big health sponsor of the "2016 Global SME Summit - Presidential Forum", and the chairman of Kanglong Bio Group took a close photo with the former President of Germany, Mr. Wulff (Picture 1), and the former Prime Minister of South Korea, Mr. Lee Soo-sung (Picture 2) Vision and Mission Vision of the Company: To become a leading company in the field of global health testing. Company's mission: Through our products and services, we are committed to reducing the incidence of major human diseases.
Legal representative: Zhang Li
Established: 2016-05-23
Registered capital: 10 million yuan
Industrial and Commercial Registration No.: 330212000541295
Enterprise type: limited liability company (natural person invested or controlled)
Corporate address: Ningbo City, China Room 1303, No. 1107, Tiantong North Road, Yinzhou District